These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 27481837)

  • 1. Spatial Heterogeneity in the Tumor Microenvironment.
    Yuan Y
    Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27481837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One microenvironment does not fit all: heterogeneity beyond cancer cells.
    Kim IS; Zhang XH
    Cancer Metastasis Rev; 2016 Dec; 35(4):601-629. PubMed ID: 27858305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-driven intratumor heterogeneity and immune evasion.
    Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
    Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Imaging of Pro- and Antitumoral Cellular Components of the Tumor Microenvironment.
    Helfen A; Roth J; Ng T; Eisenblaetter M
    J Nucl Med; 2018 Feb; 59(2):183-188. PubMed ID: 29217734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of spatial immune profiles in human solid cancers.
    Tsujikawa T; Mitsuda J; Ogi H; Miyagawa-Hayashino A; Konishi E; Itoh K; Hirano S
    Cancer Sci; 2020 Oct; 111(10):3426-3434. PubMed ID: 32726495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology.
    Heindl A; Nawaz S; Yuan Y
    Lab Invest; 2015 Apr; 95(4):377-84. PubMed ID: 25599534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravital Insights into Heterogeneity, Metastasis, and Therapy Responses.
    Scheele CLGJ; Maynard C; van Rheenen J
    Trends Cancer; 2016 Apr; 2(4):205-216. PubMed ID: 28741572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of the tumor microenvironment in the therapeutic management of cancer.
    Pottier C; Wheatherspoon A; Roncarati P; Longuespée R; Herfs M; Duray A; Delvenne P; Quatresooz P
    Expert Rev Anticancer Ther; 2015; 15(8):943-54. PubMed ID: 26098949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors.
    Newton JM; Hanoteau A; Sikora AG
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29939180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing intra-tumoral heterogeneity and therapy resistance.
    Rybinski B; Yun K
    Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
    Stanta G; Bonin S
    Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.
    Thoma CR; Zimmermann M; Agarkova I; Kelm JM; Krek W
    Adv Drug Deliv Rev; 2014 Apr; 69-70():29-41. PubMed ID: 24636868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine-grained simulations of the microenvironment of vascularized tumours.
    Fredrich T; Rieger H; Chignola R; Milotti E
    Sci Rep; 2019 Aug; 9(1):11698. PubMed ID: 31406276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor microenvironment.
    Weber CE; Kuo PC
    Surg Oncol; 2012 Sep; 21(3):172-7. PubMed ID: 21963199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational pathology: Exploring the spatial dimension of tumor ecology.
    Nawaz S; Yuan Y
    Cancer Lett; 2016 Sep; 380(1):296-303. PubMed ID: 26592351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and non-genetic clonal diversity in cancer evolution.
    Black JRM; McGranahan N
    Nat Rev Cancer; 2021 Jun; 21(6):379-392. PubMed ID: 33727690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer evolution: A means by which tumors evade treatment.
    Zhu X; Li S; Xu B; Luo H
    Biomed Pharmacother; 2021 Jan; 133():111016. PubMed ID: 33246226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.